Iodine mines clinical data to help consumers make better decisions about drugs. We crunch open government datasets (FDA, CMS, VA) to create targeted, actionable tools that drive better decisions, better adherence, and better outcomes. Iodine combines large healthcare datasets with a user's individual needs and background to create a personalized resource for better understanding and decision-making about health.
Iodine addresses a massive need among Internet users: 23% are searching for drug information, and half of these are unsatisfied by what they find. We believe that too much information offered to patients today is generic, anecdotal, and out-of-date. We believe that data science can create better information that will improve adherence, enhance behavior, and make people more confident about their health.
Geography: San Francisco, CA, USA
Other Investors: SV Angel, Maveron, Felicis Ventures, BoxGroup, and Jeremy Stoppelman.
Acquired by Goodrx